DISCOVER CUTTING EDGE NUCLEAR MEDICINE RESEARCH
Queen’s University Belfast is conducting cutting-edge research to advance diagnostic imaging and therapeutic interventions. Through interdisciplinary collaboration and emerging technologies, our researchers are at the forefront of advancing knowledge and clinical practice in this dynamic field.
From developing novel radiopharmaceuticals to refining imaging techniques and therapeutic protocols, our work encompasses a broad spectrum of applications, including oncology, cardiology, neurology, and beyond. With a commitment to precision medicine and patient centred care, Queen's University Belfast is dedicated to shaping the future of Nuclear Medicine through pioneering research and transformative discoveries.
RADIOTHERAPY
Queen's University Belfast is engaged in diverse research endeavours within the realm of radiation oncology. The research conducted at Queen’s demonstrates a dedication to advancing knowledge, improving treatment methodologies, and enhancing patient outcomes in the realm of cancer care and diagnostic imaging.
- Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy
- Modulating tumour metabolism enhances gold nanoparticle radiosensitisation in HPV-negative head and neck cancer
- Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol
- Procedure guidelines for radionuclide myocardial perfusion i... : Nuclear Medicine Communications
- Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
CANCER RESEARCH
Queen's research aims to explore enhanced strategies for preventing, detecting, and treating various types of cancers. We delve into the biological intricacies of cancer development, treatment responses, and resistance mechanisms while examining the impact of social and environmental factors on cancer risks. At Queen’s we prioritise clinical research initiatives aimed at translating fundamental discoveries into tangible advancements in patient care through rigorous clinical trials.
- A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer — Queen's University Belfast
- European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
- Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids
- Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
CARDIAC INFECTION/INFLAMMATION
Research at Queen’s is enhancing our grasp of cardiac infections and inflammation through innovative methods pinpointing these conditions within the heart. This research is driving personalised care strategies, optimising outcomes in cardiac health.
- The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study
- Dose-dependent changes in cardiac function, strain and remodelling in a preclinical model of heart base irradiation — Queen's University Belfast
- Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis
- Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans
